Innovation and Discovery

Founded in the Department of Emergency Medicine at Emory, we lead highly collaborative innovation that reimagines the acute care continuum and serves the needs of diverse patient populations. Our unique footprint across academic, community, and safety-net hospitals enables us to universally design for technology enabled models of care delivery that are effortless and equitable.

Emergency Medicine is also about preventing injuries before they occur. The IPRCE focuses on these areas: transportation safety, drug safety, violence, falls, and traumatic brain injuries.

Photo: Dr. Sharon Nieb (IPRCE Associate Program Director) presented "Investigating Pediatric Falls: Ages 0-4 in Georgia" at the Society for Advancement of Violence and Injury Research (SAVIR) conference in Ann Arbor, Michigan

The Emory Neurotrauma Translational Research Center (ENTiRE) is a cutting-edge interdisciplinary research hub at Emory University. By fostering collaboration and innovation, ENTiRE aims to accelerate the discovery and translation of groundbreaking therapies for neurotrauma.

The overarching goal of the Translational Neurotrauma Research Laboratory is to accelerate the discovery and translation of new treatments for traumatic brain injury (TBI), spinal cord injury (SCI) and neuropathic pain. We develop, characterize, and utilize highly clinically-relevant small and large animal models to achieve this goal. We test novel therapies including drugs, devices, and combination therapies to protect, repair, and restore function of the central nervous system after injury. All research is conducted with rigorous quality management to enhance the reproducibility, transparency, and translational impact of our research.

ARC oversees multicenter clinical trials coordination inside and outside of Emory. ARC provides trial design, scientific leadership, operations and logistics, finance and budgeting, regulatory, and analysis for multicenter clinical trials.